
About Ligandal
Ligandal is a company based in Oakland (United States) founded in 2013. Ligandal has raised $64 thousand across 1 funding round. Ligandal operates in a competitive market with competitors including eGenesis, Beam Therapeutics, Korro Bio, Liquidia and Scribe Therapeutics, among others.
- Headquarter Oakland, United States
- SectorsHealthcareTechnology
- Website ligandal.com
- Total Equity Funding$64K (USD)
in 1 rounds
- Latest Funding Round$64K (USD), Seed
Jan 2014
Funding Insights of Ligandal
Ligandal has successfully raised a total of $64K through 1 strategic funding round. The most recent funding activity was a Seed round of $64 thousand completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $64,000
- Total Rounds 1
- Last Round Seed β $64,000
- First Round $64,000
(Jan 2014)
All 1 funding rounds of Ligandal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2014 | $64,000 | Seed | β | β | β |
People of Ligandal
12 people are tracked at Ligandal (6 in leadership, 6 in board & advisors).
| Name | Role | Group |
|---|---|---|
Adam Stein | Chief Scientific Officer | Leadership |
☤ Bryce Chaney, MBA | Head Of Business Development | Leadership |
Daniel B. (Olu) Fagbuyi, M.D. | Chief Medical Officer & Executive Vice President of Business Development & Governmental Affairs | Leadership |
Diana Douglas | Executive Assistant to the CEO | Leadership |
Andre Watson | Founder, Chairman & CEO | Leadership |
Tushar Nuwal | CBO & COO | Leadership |
Rosemarie Truman | Advisor | Board & advisors |
Agnieszka Czechowicz | Advisor | Board & advisors |
Jeff Karp | Advisor | Board & advisors |
Robert Stroud | Advisor | Board & advisors |
Jack Lewin | Advisor | Board & advisors |
Stephen Delellis | Advisor | Board & advisors |
Complete people profiles for Ligandal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ligandal
2 dated milestones of Ligandal across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Ligandal is founded.
- Funding First funding round of $64K.
Competitors of Ligandal
Ligandal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eGenesis, Beam Therapeutics, Korro Bio, Liquidia and Scribe Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| egenesisbio.com | 2015 | Cambridge, United States | $481.42M | 94 | Gene transplantation platform for humanizing pig cells is developed. | |
| beamtx.com | 2017 | Cambridge, United States | $222M | 340 | Developer of gene therapy using CRISPR base editing to treat diseases | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| liquidia.com | 2004 | United States | $75.3M | 63 | Engineered particles & films for life and material sciences applications | |
| scribetx.com | 2018 | Alameda, United States | $120M | – | A CRISPR-based gene-editing platform is developed for therapeutic applications. | |
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| tesseratherapeutics.com | 2017 | Cambridge, United States | $610M | 149 | New genome engineering technology is provided for treating multiple diseases. | |
| locus-bio.com | 2015 | Raleigh, United States | $67.33M | 74 | Developer of therapeutics for infectious disease and inflammatory indications | |
| metagenomi.co | 2016 | Berkeley, United States | $376.37M | – | Next-generation gene editing tools are developed for drug enhancement. |
Detailed competitors of Ligandal
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ligandal
Websites that share an audience with Ligandal (ligandal.com).
Websites whose visitors overlap most with Ligandal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bplifescience.com | bplifescience.com | 100% | – | – | β |
| altrubio.com | 98% | 2.3K | #7,696,601 | View details | |
| mandalmed.com | 98% | 1.3K | #14,142,095 | View details | |
| corvuspharma.com | 97% | 13.6K | #3,366,661 | View details | |
| tempobioscience.com | 97% | 6.1K | #3,342,449 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 30 similar websites and full traffic analytics for Ligandal
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Ligandal
Complete news archive for Ligandal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Ligandal
10 companies that operate in the same segment as Ligandal (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ligandal
Ligandal was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Ligandal is headquartered in Oakland, United States. It is registered at Oakland, California, United States.
Ligandal is a funded company, having raised a total of $64K across 1 funding round to date. The company's 1st funding round was a Seed of $64K, raised on Jan 2014.
Ligandal was founded in 2013 and is based in Oakland, United States, operating in the biotechnology sector. Proprietary nanoparticle platforms are developed for targeted delivery of drugs and non-viral genome editing tools, such as CRISPR and TALENs, to specific cells and organelles. Effectiveness has been demonstrated through in vitro and in vivo experiments, supporting applications in biological process control.
Ligandal's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.
